School of Medicine
Showing 1-20 of 338 Results
-
Benjamin Pooya Fahimian
Clinical Associate Professor, Radiation Oncology - Radiation Physics
Current Research and Scholarly Interests Brachytherapy (Prostate, Gynecological, and Ocular Carcinoma)
High Dose Rate Brachytherapy Delivery Techniques
Stereotactic Radiosurgery
Trajectory Modulated Arc Therapy
Total Body and Total Skin Irradiation Techniques
Image Guided Radiotherapy -
Theodore Fainstat
Professor of Obstetrics and Gynecology, Emeritus
Current Research and Scholarly Interests Gynecologic and obstetric infections.
-
Robert Michael Fairchild
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly Interests Dr. Fairchild’s research interests center on novel applications of ultrasonography in rheumatologic disease. Current active research endeavors include using ultrasound 1) to evaluate articular and soft tissue manifestations of systemic sclerosis, 2) to screen, detect and monitor of connective tissue disease associated interstitial lung disease, 3) and to examine the incidence of immune checkpoint inhibitor related adverse events and inflammatory arthritis.
-
Alice C. Fan
Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
-
Amy Fan
Ph.D. Student in Immunology, admitted Autumn 2016
Current Research and Scholarly Interests Inherited mutations in the RUNX1 gene cause a platelet disorder and increased risk of blood cancers. However, it is still unclear what actually causes progression to cancer in these patients. Using genetic editing, I am investigating how RUNX1 mutations contribute to disease.
